- Home
- LBTYB vs VKTX Comparison
LBTYB vs VKTX Comparison
Compare LBTYB & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBTYB
- VKTX
- Stock Information
- Founded
- LBTYB 2004
- VKTX 2012
- Country
- LBTYB Bermuda
- VKTX United States
- Employees
- LBTYB N/A
- VKTX N/A
- Industry
- LBTYB Cable & Other Pay Television Services
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- LBTYB Telecommunications
- VKTX Health Care
- Exchange
- LBTYB Nasdaq
- VKTX Nasdaq
- Market Cap
- LBTYB N/A
- VKTX 3.4B
- IPO Year
- LBTYB N/A
- VKTX 2015
- Fundamental
- Price
- LBTYB $11.64
- VKTX $24.15
- Analyst Decision
- LBTYB
- VKTX Strong Buy
- Analyst Count
- LBTYB 0
- VKTX 11
- Target Price
- LBTYB N/A
- VKTX $95.18
- AVG Volume (30 Days)
- LBTYB 852.0
- VKTX 3.8M
- Earning Date
- LBTYB 01-01-0001
- VKTX 04-23-2025
- Dividend Yield
- LBTYB N/A
- VKTX N/A
- EPS Growth
- LBTYB N/A
- VKTX N/A
- EPS
- LBTYB 4.23
- VKTX N/A
- Revenue
- LBTYB $4,341,900,000.00
- VKTX N/A
- Revenue This Year
- LBTYB $2.03
- VKTX N/A
- Revenue Next Year
- LBTYB N/A
- VKTX N/A
- P/E Ratio
- LBTYB $2.57
- VKTX N/A
- Revenue Growth
- LBTYB 5.49
- VKTX N/A
- 52 Week Low
- LBTYB $10.34
- VKTX $23.27
- 52 Week High
- LBTYB $21.90
- VKTX $82.00
- Technical
- Relative Strength Index (RSI)
- LBTYB 49.67
- VKTX 33.93
- Support Level
- LBTYB $11.60
- VKTX $25.80
- Resistance Level
- LBTYB $12.07
- VKTX $29.60
- Average True Range (ATR)
- LBTYB 0.13
- VKTX 1.61
- MACD
- LBTYB 0.01
- VKTX -0.30
- Stochastic Oscillator
- LBTYB 18.31
- VKTX 10.72
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.